ERBB2 and ductal breast carcinoma in situ: With respect to the histologic subtype (p = 0.399), DCIS status (p = 0.543), size (p = 0.997), T stage (p = 0.120), and HER2 status (p = 0.297) of the tumors, there was no significant difference between the groups.